Transcriptional regulation of TNF/LT locus in immune cells

Molecular Biology

Volumn 45, Issue 1, 2011, Pages 47-57

  Shebzukhov, Yu V ^a   Kuprash, D V ^b,c  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

chromatin; enhancer; inflammation; initiation of transcription; promoter

Indexed keywords

EID: 79951973958     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893311010110     Document Type: Article

References (104)

1. Locksley R. M., Killeen N., Lenardo M. J. 2001. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell. 104, 487-501.
2. Tracey K. J., Cerami A. 1994. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503.
3. Grivennikov S. I., Kuprash D. V., Liu Z. G., Nedospasov S. A. 2006. Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. Int. Rev. Cytol. 252, 129-161.
4. Feldmann M., Maini R. N. 2003. Lasker Clinical Medical Research Award: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nature Med. 9, 1245-1250.
5. Coussens L. M., Werb Z. 2002. Inflammation and cancer. Nature. 420, 860-867.
6. Feldmann M., Maini R. N. 2001. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163-196.
7. Fu Y. X., Chaplin D. D. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17, 399-433.
8. Jongeneel C. V., Shakhov A. N., Nedospasov S. A., Cerottini J. C. 1989. Molecular control of tissue-specific expression at the mouse TNF locus. Eur. J. Immunol. 19, 549-552.
9. Kuprash D. V., Alimzhanov M. B., Pokholok D. K., Kozlov S. V., Novobrantseva T. I., Turetskaya R. L., Nedospasov S. A. 1994. Characterization of mouse chromosome 17 locus containing three genes of the tumor necrosis factor family, including the gene coding for the lymphotoxin transmembrane subunit (LT-beta). Dokl. Akad. Nauk. 337, 683-686.
10. Jongeneel C. V. 1995. Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology. 193, 210-216.
11. Nedospasov S. A. 2003. Tumor necrosis factor and lymphotoxin: Molecular genetics, regulation, and physiological role. Genetika (Moscow). 39, 207-214.
12. Falvo J. V., Tsytsykova A. V., Goldfeld A. E. 2010. Transcriptional control of the TNF gene. Curr. Dir. Autoimmun. 11, 27-60.
13. Taylor J. M., Wicks K., Vandiedonck C., Knight J. C. 2008. Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements. Nucleic Acids Res. 36, 4845-4862.
14. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., Gregory L., Lonie L., Chew A., Wei C. L., Ragoussis J., Natoli G. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity. 32, 317-328.
15. Kuprash D. V., Tumanov A. V., Liepinsh D. J., Koroleva E. P., Drutskaya M. S., Kruglov A. A., Shakhov A. N., Southon E., Murphy W. J., Tessarollo L., Grivennikov S. I., Nedospasov S. A. 2005. Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur. J. Immunol. 35, 1592-1600.
16. De Togni P., Goellner J., Ruddle N. H., Streeter P. R., Fick A., Mariathasan S., Smith S. C., Carlson R., Shornick L. P., Strauss-Schoenberger J. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264, 703-707.
17. Liepinsh D. J., Grivennikov S. I., Klarmann K. D., Lagarkova M. A., Drutskaya M. S., Lockett S. J., Tessarollo L., McAuliffe M., Keller J. R., Kuprash D. V., Nedospasov S. A. 2006. Novel lymphotoxin alpha (LT-alpha) knockout mice with unperturbed tumor necrosis factor expression: Reassessing LT alpha biological functions. Mol. Cell Biol. 26, 4214-4225.
18. Tsytsykova A. V., Rajsbaum R., Falvo J. V., Ligeiro F., Neely S. R., Goldfeld A. E. 2007. Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers. Proc. Natl. Acad. Sci. U. S. A. 104, 16850-16855.
19. Krausgruber T., Saliba D., Ryzhakov G., Lanfrancotti A., Blazek K., Udalova I. A. 2010. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 115, 4421-4430.
20. Williams A., Spilianakis C. G., Flavell R. A. 2010. Interchromosomal association and gene regulation in trans. Trends Genet. 26, 188-197.
21. Tsytsykova A. V., Goldfeld A. E. 2002. Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol. Cell Biol. 22, 2620-2631.
22. Panne D., Maniatis T., Harrison S. C. 2007. An atomic model of the interferon-beta enhanceosome. Cell. 129, 1111-1123.
23. Chodavarapu R. K., Feng S., Bernatavichute Y. V., Chen P.-Y., Stroud H., Yu Y., Hetzel J. A., Kuo F., Kim J., Cokus S. J., Casero D., Bernal M., Huijser P., Clark A. T., Kramer U., Merchant S. S., Zhang X., Jacobsen S. E., Pellegrini M. 2010. Relationship between nucleosome positioning and DNA methylation. Nature. 466, 388-392.
24. Choi J. K. 2010. Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biol. 11, R70.
25. Kochanek S., Radbruch A., Tesch H., Renz D., Doerfler W. 1991. DNA methylation profiles in the human genes for tumor necrosis factors alpha and beta in subpopulations of leukocytes and in leukemias. Proc. Natl. Acad. Sci. U. S. A. 88, 5759-5763.
26. Kochanek S., Toth M., Dehmel A., Renz D., Doerfler W. 1990. Interindividual concordance of methylation profiles in human genes for tumor necrosis factors alpha and beta. Proc. Natl. Acad. Sci. U. S. A. 87, 8830-8834.
27. Jenuwein T., Allis C. D. 2001. Translating the histone code. Science. 293, 1074-1080.
28. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21.
29. Hargreaves D. C., Horng T., Medzhitov R. 2009. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell. 138, 129-145.
30. Berger S. L. 2007. The complex language of chromatin regulation during transcription. Nature. 447, 407-412.
31. Ramirez-Carrozzi V. R., Braas D., Bhatt D. M., Cheng C. S., Hong C., Doty K. R., Black J. C., Hoffmann A., Carey M., Smale S. T. 2009. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell. 138, 114-128.
32. Smallie T., Ricchetti G., Horwood N. J., Feldmann M., Clark A. R., Williams L. M. 2010. IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages. J. Exp. Med. (in press).
33. Adelman K., Kennedy M. A., Nechaev S., Gilchrist D. A., Muse G. W., Chinenov Y., Rogatsky I. 2009. Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. Proc. Natl. Acad. Sci. U. S. A. 106, 18207-18212.
34. Biragyn A., Nedospasov S. A. 1995. Lipopolysaccharide-induced expression of TNF-alpha gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. J. Immunol. 155, 674-683.
35. El Gazzar M., Yoza B. K., Chen X., Hu J., Hawkins G. A., McCall C. E. 2008. G9a and HP1 couple histone and DNA methylation to TNF transcription silencing during endotoxin tolerance. J. Biol. Chem. 283, 32198-32208.
36. Takei S., Fernandez D., Redford A., Toyoda H. 1996. Methylation status of 5′-regulatory region of tumor necrosis factor alpha gene correlates with differentiation stages of monocytes. Biochem. Biophys. Res. Commun. 220, 606-612.
37. Sullivan K. E., Reddy A. B., Dietzmann K., Suriano A. R., Kocieda V. P., Stewart M., Bhatia M. 2007. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell Biol. 27, 5147-5160.
38. Millet I., Ruddle N. H. 1994. Differential regulation of lymphotoxin (LT), lymphotoxin-beta (LT-beta), and TNF-alpha in murine T cell clones activated through the TCR. J. Immunol. 152, 4336-4346.
39. Tumanov A., Kuprash D., Lagarkova M., Grivennikov S., Abe K., Shakhov A., Drutskaya L., Stewart C., Chervonsky A., Nedospasov S. 2002. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity. 17, 239-250.
40. Grivennikov S. I., Tumanov A. V., Liepinsh D. J., Kruglov A. A., Marakusha B. I., Shakhov A. N., Murakami T., Drutskaya L. N., Forster I., Clausen B. E., Tessarollo L., Ryffel B., Kuprash D. V., Nedospasov S. A. 2005. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity. 22, 93-104.
41. Tumanov A. V., Grivennikov S. I., Kruglov A. A., Shebzukhov Y. V., Koroleva E. P., Piao Y., Cui C. Y., Kuprash D. V., Nedospasov S. A. 2010. Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs. Blood. 116 (in press).
42. Pokholok D. K., Maroulakou I. G., Kuprash D. V., Alimzhanov M. B., Kozlov S. V., Novobrantseva T. I., Turetskaya R. L., Green J. E., Nedospasov S. A. 1995. Cloning and expression analysis of the murine lymphotoxin beta gene. Proc. Natl. Acad. Sci. U. S. A. 92, 674-678.
43. Boitchenko V. E., Alimzhanov M. V., Turetskaya R. L., Ruhlmann A., Nordheim A., Kuprash D. V., Nedospasov S. A. 2001. Comparative characterization of lymphotoxin transcripts from human B- and T-cell lines, peripheral lymphocytes, and normal tissues. Mol. Biol. (Moscow). 35, 115-121.
44. Kuprash D. V., Osipovich O. A., Pokholok D. K., Alimzhanov M. B., Biragyn A., Turetskaya R. L., Nedospasov S. A. 1996. Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation. J. Immunol. 156, 2465-2472.
45. Kaminuma O., Kitamura F., Kitamura N., Hiroi T., Miyoshi H., Miyawaki A., Miyatake S. 2008. Differential contribution of NFATc2 and NFATc1 to TNF-α gene expression in T cells. J. Immunol. 180, 319-326.
46. Kuprash D. V., Udalova I. A., Turetskaya R. L., Rice N. R., Nedospasov S. A. 1995. Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: Distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene. 11, 97-106.
47. Kwon J., Lee S. J., Benveniste E. N. 1996. A 3′-cis-acting element is involved in tumor necrosis factor-alpha gene expression in astrocytes. J. Biol. Chem. 271, 22383-22390.
48. Kuprash D. V., Boitchenko V. E., Yarovinsky F. O., Rice N. R., Nordheim A., Ruhlmann A., Nedospasov S. A. 2002. Cyclosporin A blocks the expression of lymphotoxin alpha, but not lymphotoxin beta, in human peripheral blood mononuclear cells. Blood. 100, 1721-1727.
49. Messer G., Weiss E. H., Baeuerle P. A. 1990. Tumor necrosis factor beta (TNF-beta) induces binding of the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter. Cytokine. 2, 389-397.
50. Paul N. L., Lenardo M. J., Novak K. D., Sarr T., Tang W. L., Ruddle N. H. 1990. Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: Role for NF-kappa B. J. Virol. 64, 5412-5419.
51. Paul N. L., Millet I., Ruddle N. H. 1993. The lymphotoxin promoter is stimulated by HTLV-I tax activation of NF-kappa B in human T-cell lines. Cytokine. 5, 372-378.
52. Tschachler E., Bohnlein E., Felzmann S., Reitz M. S., Jr. 1993. Human T-lymphotropic virus type I tax regulates the expression of the human lymphotoxin gene. Blood. 81, 95-100.
53. Worm M. M., Tsytsykova A., Geha R. S. 1998. CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. Eur. J. Immunol. 28, 901-906.
54. Kovanen P. E., Young L., Al-Shami A., Rovella V., Pise-Masison C. A., Radonovich M. F., Powell J., Fu J., Brady J. N., Munson P. J., Leonard W. J. 2005. Global analysis of IL-2 target genes: Identification of chromosomal clusters of expressed genes. Int. Immunol. 17, 1009-1021.
55. McBride W. H., Economou J. S., Nayersina R., Comora S., Essner R. 1990. Influences of Interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes. Cancer Res. 50, 2949-2952.
56. Remick D. G., Nguyen D. T., Eskandari M. K., Kunkel S. L. 1991. Interleukin 2 induces tumor necrosis factor gene expression in vivo. Immunol. Invest. 20, 395-405.
57. Strieter R. M., Remick D. G., Lynch J. P., 3rd, Spengler R. N., Kunkel S. L. 1989. Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes. Am. Rev. Respir. Dis. 139, 335-342.
58. Wei S., Blanchard D., Liu J., Leonard W., Djeu J. 1993. Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta. J. Immunol. 150, 1979-1987.
59. Lu L., Zhu J., Zheng Z., Yan M., Xu W., Sun L., Theze J., Liu X. 1998. Jak-STAT pathway is involved in the induction of TNF-beta gene during stimulation by IL-2. Eur. J. Immunol. 28, 805-810.
60. Xu W., Yan M., Lu L., Sun L., Theze J., Zheng Z., Liu X. 2001. The p38 MAPK pathway is involved in the IL-2 induction of TNF-[beta] gene via the EBS element. Biochem. Biophys. Res. Commun. 289, 979-986.
61. Fiévez L., Desmet C., Henry E., Pajak B., Hegenbarth S., Garzé V., Bex F., Jaspar F., Boutet P., Gillet L., Vanderplasschen A., Knolle P. A., Leo O., Moser M., Lekeux P., Bureau F. 2007. STAT5 is an ambivalent regulator of neutrophil homeostasis. PLoS ONE. 2, e727.
62. Tumanov A. V., Grivennikov S. I., Shakhov A. N., Rybtsov S. A., Koroleva E. P., Takeda J., Nedospasov S. A., Kuprash D. V. 2003. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195, 106-116.
63. Junt T., Tumanov A. V., Harris N., Heikenwalder M., Zeller N., Kuprash D. V., Aguzzi A., Ludewig B., Nedospasov S. A., Zinkernagel R. M. 2006. Expression of lymphotoxin beta governs immunity at two distinct levels. Eur. J. Immunol. 36, 2061-2075.
64. Jungbeck M., Stopfer P., Bataille F., Nedospasov S. A., Mannel D. N., Hehlgans T. 2008. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation-opposite functions for surface lymphotoxin expressed by T and B lymphocytes. Mol. Immunol. 45, 34-41.
65. Foxwell B., Browne K., Bondeson J., Clarke C., de Martin R., Brennan F., Feldmann M. 1998. Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. Proc. Natl. Acad. Sci. U. S. A. 95, 8211-8215.
66. Wang J., Wang X., Hussain S., Zheng Y., Sanjabi S., Ouaaz F., Beg A. A. 2007. Distinct Roles of different NF-kappaB subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J. Immunol. 178, 6777-6788.
67. Shakhov A. N., Collart M. A., Vassalli P., Nedospasov S. A., Jongeneel C. V. 1990. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med. 171, 35-47.
68. El Gazzar M., Liu T., Yoza B. K., McCall C. E. 2010. Dynamic and selective nucleosome repositioning during endotoxin tolerance. J. Biol. Chem. 285, 1259-1271.
69. El Gazzar M., Yoza B. K., Chen X., Garcia B. A., Young N. L., McCall C. E. 2009. Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance. Mol. Cell Biol. 29, 1959-1971.
70. El Gazzar M., Yoza B. K., Hu J. Y.-Q., Cousart S. L., McCall C. E. 2007. Epigenetic silencing of tumor necrosis factor α during endotoxin tolerance. J. Biol. Chem. 2282, 26857-26864.
71. Ghosh C. C., Ramaswami S., Juvekar A., Vu H.-Y., Galdieri L., Davidson D., Vancurova I. 2010. Genespecific repression of proinflammatory cytokines in stimulated human macrophages by nuclear IκBα. J. Immunol. 1185, 3685-3693.
72. Gomard T., Michaud H.-A., Tempé D., Thiolon K., Pelegrin M., Piechaczyk M. 2010. An NF-κB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells. PLoS ONE. 5, e9585.
73. Kuprash D. V., Udalova I. A., Turetskaya R. L., Kwiatkowski D., Rice N. R., Nedospasov S. A. 1999. Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J. Immunol. 162, 4045-4052.
74. Drouet C., Shakhov A. N., Jongeneel C. V. 1991. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J. Immunol. 147, 1694-1700.
75. Baer M., Dillner A., Schwartz R. C., Sedon C., Nedospasov S., Johnson P. F. 1998. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol. Cell Biol. 18, 5678-5689.
76. Udalova I. A., Turetskaya R. L., Kuprash D. V., Nedospasov S. A. 1995. Two steps of tumor necrosis factor gene transcription activation in macrophages: Role of NF-kappaB/Rel proteins under the action of lipopolysaccharides. Dokl. Akad. Nauk. 342, 413-417.
77. Udalova I. A., Knight J. C., Vidal V., Nedospasov S. A., Kwiatkowski D. 1998. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273, 21178-21186.
78. O'Donnell P. M., Taffet S. M. 2002. The proximal promoter region is essential for lipopolysaccharide induction and cyclic AMP inhibition of mouse tumor necrosis factor-alpha. J. Interferon Cytokine Res. 22, 539-548.
79. Ye J., Wang L., Zhang X., Tantishaiyakul V., Rojanasakul Y. 2003. Inhibition of TNF-alpha gene expression and bioactivity by site-specific transcription factor-binding oligonucleotides. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L386-L394.
80. Means T., Pavlovich R., Roca D., Vermeulen M., Fenton M. 2000. Activation of TNF-alpha transcription utilizes distinct MAP kinase pathways in different macrophage populations. J. Leukoc. Biol. 67, 885-893.
81. Trede N. S., Tsytsykova A. V., Chatila T., Goldfeld A. E., Geha R. S. 1995. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-kappa B. J. Immunol. 155, 902-908.
82. Yao J., Mackman N., Edgington T. S., Fan S. T. 1997. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells: Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J. Biol. Chem. 272, 17795-17801.
83. Goldfeld A. E., Doyle C., Maniatis T. 1990. Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 87, 9769-9773.
84. Rao P., Hayden M. S., Long M., Scott M. L., West A. P., Zhang D., Oeckinghaus A., Lynch C., Hoffmann A., Baltimore D., Ghosh S. 2010. IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature. 466, 1115-1119.
85. Tsytsykova A. V., Falvo J. V., Schmidt-Supprian M., Courtois G., Thanos D., Goldfeld A. E. 2007. Post-induction, stimulus-specific regulation of tumor necrosis factor mRNA expression. J. Biol. Chem. 282, 11629-11638.
86. Denys A., Udalova I. A., Smith C., Williams L. M., Ciesielski C. J., Campbell J., Andrews C., Kwaitkowski D., Foxwell B. M. 2002. Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J. Immunol. 168, 4837-4845.
87. Minematsu H., Shin M. J., Celil Aydemir A. B., Seo S. W., Kim D. W., Blaine T. A., Macián F., Yang J., Young-In Lee F. 2007. Orthopedic implant particle-induced tumor necrosis factor-α production in macrophage-monocyte lineage cells is mediated by nuclear factor of activated T cells. Ann. N. Y. Acad. Sci. 1117, 143-150.
88. Vila-del Sol V., Punzon C., Fresno M. 2008. IFN-γ-Induced TNF-α expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J. Immunol. 181, 4461-4470.
89. Zhao X. J., Dong Q., Bindas J., Piganelli J. D., Magill A., Reiser J., Kolls J. K. 2008. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J. Immunol. 181, 3049-3056.
90. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S.-i., Honda K., Ohba Y., Mak T. W., Taniguchi T. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 434, 243-249.
91. Fukai T., Nishiyama C., Kanada S., Nakano N., Hara M., Tokura T., Ikeda S., Ogawa H., Okumura K. 2009. Involvement of PU. 1 in the transcriptional regulation of TNF-[alpha]. Biochem. Biophys. Res. Commun. 388, 102-106.
92. Niwa Y., Nishiyama C., Nakano N., Kamei A., Kato H., Kanada S., Ikeda S., Ogawa H., Okumura K. 2008. Opposite effects of PU. 1 on mast cell stimulation. Biochem. Biophys. Res. Commun. 375, 95-100.
93. Klein M., Klein-Hessling S., Palmetshofer A., Serfling E., Tertilt C., Bopp T., Heib V., Becker M., Taube C., Schild H., Schmitt E., Stassen M. 2006. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J. Immunol. 177, 6667-6674.
94. Cloutier A., Ear T., Blais-Charron E., Dubois C. M., McDonald P. P. 2007. Differential involvement of NF-κB and MAP kinase pathways in the generation of inflammatory cytokines by human neutrophils. J. Leukoc. Biol. 81, 567-577.
95. Cloutier A., Ear T., Borissevitch O., Larivee P., McDonald P. P. 2003. Inflammatory cytokine expression is independent of the c-Jun N-terminal kinase/AP-1 signaling cascade in human neutrophils. J. Immunol. 171, 3751-3761.
96. Cloutier A., Guindi C., Larivee P., Dubois C. M., Amrani A., McDonald P. P. 2009. Inflammatory cytokine production by human neutrophils involves C/EBP transcription factors. J. Immunol. 182, 563-571.
97. Garrett W. S., Lord G. M., Punit S., Lugo-Villarino G., Mazmanian S. K., Ito S., Glickman J. N., Glimcher L. H. 2007. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 131, 33-45.
98. GeurtsvanKessel C. H., Willart M. A. M., Bergen I. M., van Rijt L. S., Muskens F., Elewaut D., Osterhaus A. D. M. E., Hendriks R., Rimmelzwaan G. F., Lambrecht B. N. 2009. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206, 2339-2349.
99. Lu G., Janjic B. M., Janjic J., Whiteside T. L., Storkus W. J., Vujanovic N. L. 2002. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta (2), Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol. 168, 1831-1839.
100. Vernal R., Leon R., Herrera D., Garcia-Sanz J. A., Silva, Sanz M. 2008. Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans. J. Periodont. Res. 43, 689-697.
101. Kuprash D. V., Alimzhanov M. B., Tumanov A. V., Anderson A. O., Pfeffer K., Nedospasov S. A. 1999. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes. J. Immunol. 163, 6575-6580.
102. Tomaras G. D., Foster D. A., Burrer C. M., Taffet S. M. 1999. ETS transcription factors regulate an enhancer activity in the third intron of TNF-alpha. J. Leukoc. Biol. 66, 183-193.
103. Barthel R., Goldfeld A. E. 2003. T cell-specific expression of the human TNF-alpha gene involves a functional and highly conserved chromatin signature in intron 3. J. Immunol. 171, 3612-3619.
104. Tumanov A. V., Nedospasov S. A., Turetskaya R. L. 1998. Chromatin organization in the tumor necrosis factor/lymphotoxin gene locus: correlation with tissue-specific expression. Mol. Biol. (Moscow). 32, 83-87.